Forbes - (Mostly) Good Vaccine News

Plus: NYC to resume indoor dining on Valentine’s Day

Johnson & Johnson released a press release today with the results on how effective its Covid-19 vaccine is-- and the results are encouraging. With only one shot, the vaccine is 66% effective at preventing moderate and severe Covid-19, and 100% effective at preventing hospitalizations and deaths for the disease. It’s great to have a new vaccine option in the global arsenal, even though the vaccine has yet to be granted an emergency use authorization by the FDA. And there’s more good vaccine news: a Covid-19 vaccine created by biotech company Novavax seems to be highly effective against the more contagious B.1.1.7 variant of Covid-19 that was discovered in the U.K. Unfortunately, both the J&J and Novavax vaccine struggled more when it came to preventing the 501Y.V2 variant that is circulating now in South Africa.

Business

More than 50 lawmakers are urging President Biden to include recurring stimulus checks in the new Covid-19 relief bill. 

The pharmaceutical industry was under stress before the Covid-19 pandemic-- and it’s even worse now. Here’s what needs to change. 

Science & Health

A new study shows that a combination antibody treatment from Eli Lilly can help treat Covid-19. 

We know that Covid-19 can affect the nervous system; now researchers are tracking the virus’ effect on the brain. 

A new report shows that women in multiple countries have experienced increased stress and household work due to the pandemic. 

On The Upside

More Reasons To Mask Up: Mask wearing works -- not only to help prevent new variants of the virus, but also to help boost the economy.